Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

New study may help devise better treatment strategies for cancer and heart disease

Research led by T. Cooper Woods, PhD, Assistant Professor of Pharmacology and Experimental Therapeutics at LSU Health Sciences Center New Orleans, and Director of the Molecular Cardiology Research Laboratory at Ochsner Clinic Foundation, has identified the mechanism of how a drug commonly used on stents to prevent reclosure of coronary arteries, regulates cell movement which is critical to wound healing and the progression of diseases like cancer.

16 Apr 2010

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.

15 Apr 2010

Tengion completes initial 6M common stock public offering

Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.

15 Apr 2010

New UCLA study compares safety and efficacy of angioplasty to bypass surgery

At 56, Tim Obrenski found himself getting so exhausted that he couldn't even pull weeds from his garden. A visit to the cardiologist uncovered a major blockage in his heart's left main artery, and he was told he needed bypass surgery.

15 Apr 2010

FDA approves Sagent Pharmaceuticals' two ANDAs to market granisetron

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the Company's two abbreviated New Drug Applications to market granisetron hydrochloride injection, USP (granisetron), an antiemetic used to prevent nausea and vomiting caused by chemotherapy.

15 Apr 2010

First patient enrolled in Endologix percutaneous EVAR pivotal clinical trial

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that the first patient has been enrolled in the Company's prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair.

15 Apr 2010

Brains on Bikes raises funds for brain cancer research and support

Anne Feeley, a 55-year-old mother and brain cancer survivor, began a 3,781-mile ride across the country today to raise money and awareness for brain cancer research and support.

12 Apr 2010

U-M Medical School researchers earn $366M in NIH research funding in fiscal year 2009

University of Michigan Medical School physicians and scientists earned more than $366 million in National Institutes of Health research funding in federal fiscal year 2009, according to NIH data. In all, the School's faculty brought in more than $435 million in research funding from all sources in U-M fiscal year 2009.

12 Apr 2010

Cordis commences enrollment in safety trial of INCRAFT stent graft system for AAA

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technologies, announced today that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system, called INCRAFT™, to treat abdominal aortic aneurysm (AAA). An estimated 27 million people worldwide have abdominal aortic aneurysms.

9 Apr 2010

Svelte Medical Systems' Series A extension financing oversubscribed

Svelte Medical Systems, Inc. is pleased to announce that it has successfully completed the extension of its Series A financing from institutional and private investors including CNF Investments, Apjohn Ventures and the Fischell family. The company's Series A extension was oversubscribed and included an initial investment by Norwich Ventures LP. Norwich Ventures is a seed and early-stage venture capital firm committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies.

9 Apr 2010

SIR, Custom Computer Specialists sign licensing agreement to promote development of HI-IQ

The Society of Interventional Radiology and Custom Computer Specialists Inc. have entered into an exclusive, long-term licensing agreement to promote innovation and the development of HI-IQ-, the leading information management system for interventional radiology.

8 Apr 2010

Accumetrics completes enrollment phase of GRAVITAS clinical trial

Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy to use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced that it has completed the enrollment phase of its landmark clinical trial, GRAVITAS.

7 Apr 2010

Two pioneering hospital systems to pilot Unity Medical's Medical Video jLog for Apple iPad

Unity Medical, Inc. a premier provider of digital health tools that enhance the patient experience today announced that two pioneering hospital systems will pilot the company's new Medical Video jLog™ for the Apple iPad™, an innovative application that utilizes short form interactive video to explain common medical procedures such as CT scans, cardiac stent placements, and physical rehabilitation treatment.

6 Apr 2010

Endovascular aortic abdominal aneurysm repair utilization associated with disease prevalence

While health policy researchers commonly suggest that geographic variations in the amount of medical care provided can be attributed to hospital costs or physician practice patterns, a new study examining regional utilization of a specific surgical procedure - minimally invasive aneurysm repair - shows that is not the case.

3 Apr 2010

Study shows imaging technique useful for planning cardiac procedures

For a patient with heart failure, checking whether the heart could benefit from bypass surgery or a stent is critical to ensuring survival. One imaging technique, positron emission tomography (PET) with the imaging agent fluorodeoxyglucose (FDG), may provide doctors with the information they need to make more informed treatment decisions, according to research published in the April issue of The Journal of Nuclear Medicine (JNM).

2 Apr 2010

MGH to create registry of patients who had OCT of coronary arteries

Massachusetts General Hospital, together with a coalition of 20 international sites in five countries, will create the world's largest registry of patients who have had optical coherence tomography of the coronary arteries.

26 Mar 2010

DSM Biomedical expands resources and operations in the U.S. and Europe

DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company’s portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.

23 Mar 2010

ChemoCentryx undertakes Phase II clinical trial of CCX140

ChemoCentryx, Inc., today announced that it has undertaken a Phase II clinical trial of CCX140, a novel, orally-available small molecule compound designed to specifically target the chemokine receptor known as CCR2.

22 Mar 2010

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.

19 Mar 2010

Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of Cardiology and the American Heart Association to intervene on only the culprit vessel.

19 Mar 2010

Stent News and Research

Further Reading

New study may help devise better treatment strategies for cancer and heart disease

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

Tengion completes initial 6M common stock public offering

New UCLA study compares safety and efficacy of angioplasty to bypass surgery

FDA approves Sagent Pharmaceuticals' two ANDAs to market granisetron

First patient enrolled in Endologix percutaneous EVAR pivotal clinical trial

Brains on Bikes raises funds for brain cancer research and support

U-M Medical School researchers earn $366M in NIH research funding in fiscal year 2009

Cordis commences enrollment in safety trial of INCRAFT stent graft system for AAA

Svelte Medical Systems' Series A extension financing oversubscribed

SIR, Custom Computer Specialists sign licensing agreement to promote development of HI-IQ

Accumetrics completes enrollment phase of GRAVITAS clinical trial

Two pioneering hospital systems to pilot Unity Medical's Medical Video jLog for Apple iPad

Endovascular aortic abdominal aneurysm repair utilization associated with disease prevalence

Study shows imaging technique useful for planning cardiac procedures

MGH to create registry of patients who had OCT of coronary arteries

DSM Biomedical expands resources and operations in the U.S. and Europe

ChemoCentryx undertakes Phase II clinical trial of CCX140

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News